Provitro stands for more than ten years of experience in
commercialisation of cell culture technologies and tissue
microarrays backed up by scientific knowledge and resources of
immunohistochemical analyses at the Pathological Institute of
Charité Universitätsmedizin Berlin. We have added medical research
to our own know-how in biotechnology to create solutions to common
problems in life sciences. Provitro’s team has raised its sights to
the interface between research and development to hammer out
brand-new solutions to the benefit of future research projects.
These are the hallmarks: competence, vision and sustainability.